MULTI-INSTITUTIONAL ANALYSIS OF CLINICAL AND IMAGING RISK FACTORS FOR DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH PI-RADS 3 LESIONS

被引：0
|
作者：
Fang, Andrew
Shumaker, Luke
Martin, Kimberly
Onah, Okechukwu
Jackson, Jamaal
Khajir, Ghazal
Fan, Richard
Soodana-Prakash, Nachiketh
Patel, Hiten
Vourganti, Srinivas
Filson, Christopher
Sprenkle, Preston
Sonn, Geoffrey
Punnen, Sanoj
Gupta, Gopal
Rais-Bahrami, Soroush
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD57-01
引用
收藏
页码：E959 / E959
页数：1
相关论文
共 50 条
  • [31] EVALUATION OF PI-RADS VERSION 2.1 VS. 2.0 FOR DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN BIOPSY-NAIVE MEN
    Mitchell, M. Huang
    Kathryn, E. Fink
    Li Eric, V.
    Mohammad, R. Siddiqui
    Nicole, Handa
    Ridwan, Alam
    Anugayarthi, Jawahar
    Edward, M. Schaeffer
    Ashley, E. Ross
    Hiten, D. Patel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 75 - 76
  • [32] Perilesional Biopsies Increase Detection of Significant Prostate Cancer in Men with PI-RADS 4/5 Lesions: Validation of the PI-RADS Steering Committee Recommendation
    Lahoud, John
    Doan, Paul
    Kim, Lawrence
    Patel, Manish I.
    EUROPEAN UROLOGY, 2021, 80 (02) : 260 - 261
  • [33] Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer
    Tavakoli, Anoshirwan Andrej
    Hielscher, Thomas
    Badura, Patrick
    Goertz, Magdalena
    Kuder, Tristan Anselm
    Gnirs, Regula
    Schwab, Constantin
    Hohenfellner, Markus
    Schlemmer, Heinz-Peter
    Bonekamp, David
    RADIOLOGY, 2023, 306 (01) : 186 - 199
  • [34] Clinical utility of PSA density and PI-RADS for deferring biopsy for the detection of clinically significant prostate cancer
    Truong, Matthew
    Stevens, Erica
    Ward, Ryan
    Bullen, Jennifer
    Austhof, Ethan
    Valdez, Rogelio
    Purysko, Andrei
    Klein, Eric A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [35] CLINICAL UTILITY OF PSA DENSITY AND PI-RADS FOR DEFERRING BIOPSY FOR THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER
    Truong, Matthew
    Stevens, Erica
    Ward, Ryan
    Bullen, Jennifer
    Austhof, Ethan
    Valdez, Rogelio
    Purysko, Andrei
    Klein, Eric
    JOURNAL OF UROLOGY, 2020, 203 : E1104 - E1104
  • [36] Effects of the lesion size on clinically significant prostate cancer detection rates in PI-RADS category 3--5 lesions
    Ayranci, A.
    Caglar, U.
    Meric, A.
    Gelmis, M.
    Sarilar, O.
    Ozgor, F.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (07): : 526 - 531
  • [37] THE UTILITY OF PSA DENSITY IN PATIENTS WITH PI-RADS 3 LESIONS ACROSS A LARGE MULTI-INSTITUTIONAL COLLABORATIVE
    Drevik, Johnathan
    Dalimov, Zafardjan
    Syed, Kaynaat
    Danella, John
    Belkoff, Laurence
    Reese, Adam
    Tomaszewski, Jeffrey
    Trabulsi, Edouard
    Singer, Eric
    Jacobs, Bruce
    Raman, Jay
    Guzzo, Thomas
    Correa, Andres
    Smaldone, Marc
    Uzzo, Robert
    Ginzburg, Serge
    JOURNAL OF UROLOGY, 2022, 207 (05): : E693 - E693
  • [38] Is PI-RADS 3/total lesion ratio associated with clinically-significant prostate cancer in patients with equivocal-risk lesions on multi-parametric MRI?
    Ghabili, Kamyar
    Swallow, Matthew
    Suarez-Sarmiento, Alfredo
    Syed, Jamil
    Leapman, Michael
    Weinreb, Jeffrey
    Sprenkle, Preston
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [39] Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative
    Drevik, Johnathan
    Dalimov, Zafardjan
    Uzzo, Robert
    Danella, John
    Guzzo, Thomas
    Belkoff, Lawrence
    Raman, Jay
    Tomaszewski, Jeffrey
    Trabulsi, Edouard
    Reese, Adam
    Singer, Eric A.
    Syed, Kaynaat
    Jacobs, Bruce
    Correa, Andres
    Smaldone, Marc
    Ginzburg, Serge
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) : 490.e1 - 490.e6
  • [40] Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer
    Nayana U. Patel
    Kimberly E. Lind
    Kavita Garg
    David Crawford
    Priya N. Werahera
    Sajal S. Pokharel
    Abdominal Radiology, 2019, 44 : 705 - 712
12345